OBJECTIVE: To determine if selected pro-inflammatory and anti-inflammatory cytokines and/or mediators of inflammation reported to be related to the development of cerebral palsy (CP) predict neurodevelopmental outcome in extremely low birth weight infants. STUDY DESIGN: Infants with birth weights ≤1000 g (n = 1067) had blood samples collected at birth and on days 3 ± 1, 7 ± 1, 14 ± 3, and 21 ± 3 to examine the association between cytokines and neurodevelopmental outcomes. The analyses were focused on 5 cytokines (interleukin [IL] 1β; IL-8; tumor necrosis factor-α; regulated upon activation, normal T-cell expressed, and secreted (RANTES); and IL-2) reported to be most predictive of CP in term and late preterm infants. RESULTS: IL-8 was higher on days 0-4 and subsequently in infants who developed CP compared with infants who did not develop CP in both unadjusted and adjusted analyses. Other cytokines (IL-12, IL-17, tumor necrosis factor-β, soluble IL rα, macrophage inflammatory protein 1β) were found to be altered on days 0-4 in infants who developed CP. CONCLUSIONS: CP in former preterm infants may, in part, have a late perinatal and/or early neonatal inflammatory origin.
OBJECTIVE: To determine if selected pro-inflammatory and anti-inflammatory cytokines and/or mediators of inflammation reported to be related to the development of cerebral palsy (CP) predict neurodevelopmental outcome in extremely low birth weight infants. STUDY DESIGN:Infants with birth weights ≤1000 g (n = 1067) had blood samples collected at birth and on days 3 ± 1, 7 ± 1, 14 ± 3, and 21 ± 3 to examine the association between cytokines and neurodevelopmental outcomes. The analyses were focused on 5 cytokines (interleukin [IL] 1β; IL-8; tumor necrosis factor-α; regulated upon activation, normal T-cell expressed, and secreted (RANTES); and IL-2) reported to be most predictive of CP in term and late preterm infants. RESULTS:IL-8 was higher on days 0-4 and subsequently in infants who developed CP compared with infants who did not develop CP in both unadjusted and adjusted analyses. Other cytokines (IL-12, IL-17, tumor necrosis factor-β, soluble IL rα, macrophage inflammatory protein 1β) were found to be altered on days 0-4 in infants who developed CP. CONCLUSIONS: CP in former preterm infants may, in part, have a late perinatal and/or early neonatal inflammatory origin.
Authors: Tuula Kaukola; Ebenezer Satyaraj; Dhavalkumar D Patel; Velizar T Tchernev; Brian G Grimwade; Stephen F Kingsmore; Pentti Koskela; Outi Tammela; Leena Vainionpää; Helena Pihko; Tuula Aärimaa; Mikko Hallman Journal: Ann Neurol Date: 2004-02 Impact factor: 10.422
Authors: E S Connolly; C J Winfree; T A Springer; Y Naka; H Liao; S D Yan; D M Stern; R A Solomon; J C Gutierrez-Ramos; D J Pinsky Journal: J Clin Invest Date: 1996-01-01 Impact factor: 14.808
Authors: John M Dagle; Kelli K Ryckman; Cassandra N Spracklen; Allison M Momany; C Michael Cotten; Joshua Levy; Grier P Page; Edward F Bell; Waldemar A Carlo; Seetha Shankaran; Ronald N Goldberg; Richard A Ehrenkranz; Jon E Tyson; Barbara J Stoll; Jeffrey C Murray Journal: J Perinatol Date: 2018-12-05 Impact factor: 2.521
Authors: Marliese Dion Nist; Rita H Pickler; Tondi M Harrison; Deborah K Steward; Abigail B Shoben Journal: Early Hum Dev Date: 2020-05-22 Impact factor: 2.079
Authors: Irina A Buhimschi; Unzila A Nayeri; Christine A Laky; Sonya-Abdel Razeq; Antonette T Dulay; Catalin S Buhimschi Journal: Expert Opin Med Diagn Date: 2012-08-17
Authors: Laura R Ment; Ulrika Ådén; Charles R Bauer; Henrietta S Bada; Waldemar A Carlo; Jeffrey R Kaiser; Aiping Lin; Charles Michael Cotten; Jeffrey Murray; Grier Page; Mikko Hallman; Richard P Lifton; Heping Zhang Journal: Semin Perinatol Date: 2015-10-26 Impact factor: 3.300
Authors: Alan Leviton; Elizabeth N Allred; Raina N Fichorova; Karl C K Kuban; T Michael O'Shea; Olaf Dammann Journal: Early Hum Dev Date: 2015-12-28 Impact factor: 2.079